{"nct_id":"NCT03317496","title":"Safety And Efficacy Study Of Avelumab Plus Chemotherapy With Or Without Other Anti-Cancer Immunotherapy Agents In Patients With Advanced Malignancies","status":"TERMINATED","status_verified_date":"2023-08","start_date":"2017-12-21","start_date_type":"ACTUAL","primary_completion_date":"2021-06-07","primary_completion_date_type":"ACTUAL","completion_date":"2022-12-20","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["PFE"]}